Insights into the biology of primary central nervous system lymphoma.

Maciej M. Mrugala, James L. Rubenstein, Maurilio Ponzoni, Tracy T. Batchelor

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Primary central nervous system lymphoma (PCNSL) is a rare variant of non-Hodgkin lymphoma that is confined to the central nervous system. Biologic studies of PCNSL are challenging to conduct because the disease is rare and available tissue material is sparse. However, in recent years there has been progress in the understanding of PCNSL biology, largely as the result of multicenter studies using modern molecular techniques. Recent studies may improve insight into the pathogenesis of PCNSL and increase the chances of identifying prognostic factors and novel therapeutic targets. This review discusses recent advances in PCNSL biology, including immunologic and genetic risk factors, and focuses on the molecular alterations important in central nervous system lymphomagenesis.

Original languageEnglish
Pages (from-to)73-80
Number of pages8
JournalCurrent Oncology Reports
Volume11
Issue number1
Publication statusPublished - Jan 2009

Fingerprint

Lymphoma
Central Nervous System
Systems Biology
Rare Diseases
Non-Hodgkin's Lymphoma
Multicenter Studies

ASJC Scopus subject areas

  • Oncology

Cite this

Mrugala, M. M., Rubenstein, J. L., Ponzoni, M., & Batchelor, T. T. (2009). Insights into the biology of primary central nervous system lymphoma. Current Oncology Reports, 11(1), 73-80.

Insights into the biology of primary central nervous system lymphoma. / Mrugala, Maciej M.; Rubenstein, James L.; Ponzoni, Maurilio; Batchelor, Tracy T.

In: Current Oncology Reports, Vol. 11, No. 1, 01.2009, p. 73-80.

Research output: Contribution to journalArticle

Mrugala, MM, Rubenstein, JL, Ponzoni, M & Batchelor, TT 2009, 'Insights into the biology of primary central nervous system lymphoma.', Current Oncology Reports, vol. 11, no. 1, pp. 73-80.
Mrugala, Maciej M. ; Rubenstein, James L. ; Ponzoni, Maurilio ; Batchelor, Tracy T. / Insights into the biology of primary central nervous system lymphoma. In: Current Oncology Reports. 2009 ; Vol. 11, No. 1. pp. 73-80.
@article{41498d05eee849b68459ca34dd17a670,
title = "Insights into the biology of primary central nervous system lymphoma.",
abstract = "Primary central nervous system lymphoma (PCNSL) is a rare variant of non-Hodgkin lymphoma that is confined to the central nervous system. Biologic studies of PCNSL are challenging to conduct because the disease is rare and available tissue material is sparse. However, in recent years there has been progress in the understanding of PCNSL biology, largely as the result of multicenter studies using modern molecular techniques. Recent studies may improve insight into the pathogenesis of PCNSL and increase the chances of identifying prognostic factors and novel therapeutic targets. This review discusses recent advances in PCNSL biology, including immunologic and genetic risk factors, and focuses on the molecular alterations important in central nervous system lymphomagenesis.",
author = "Mrugala, {Maciej M.} and Rubenstein, {James L.} and Maurilio Ponzoni and Batchelor, {Tracy T.}",
year = "2009",
month = "1",
language = "English",
volume = "11",
pages = "73--80",
journal = "Current Oncology Reports",
issn = "1523-3790",
publisher = "Current Science, Inc.",
number = "1",

}

TY - JOUR

T1 - Insights into the biology of primary central nervous system lymphoma.

AU - Mrugala, Maciej M.

AU - Rubenstein, James L.

AU - Ponzoni, Maurilio

AU - Batchelor, Tracy T.

PY - 2009/1

Y1 - 2009/1

N2 - Primary central nervous system lymphoma (PCNSL) is a rare variant of non-Hodgkin lymphoma that is confined to the central nervous system. Biologic studies of PCNSL are challenging to conduct because the disease is rare and available tissue material is sparse. However, in recent years there has been progress in the understanding of PCNSL biology, largely as the result of multicenter studies using modern molecular techniques. Recent studies may improve insight into the pathogenesis of PCNSL and increase the chances of identifying prognostic factors and novel therapeutic targets. This review discusses recent advances in PCNSL biology, including immunologic and genetic risk factors, and focuses on the molecular alterations important in central nervous system lymphomagenesis.

AB - Primary central nervous system lymphoma (PCNSL) is a rare variant of non-Hodgkin lymphoma that is confined to the central nervous system. Biologic studies of PCNSL are challenging to conduct because the disease is rare and available tissue material is sparse. However, in recent years there has been progress in the understanding of PCNSL biology, largely as the result of multicenter studies using modern molecular techniques. Recent studies may improve insight into the pathogenesis of PCNSL and increase the chances of identifying prognostic factors and novel therapeutic targets. This review discusses recent advances in PCNSL biology, including immunologic and genetic risk factors, and focuses on the molecular alterations important in central nervous system lymphomagenesis.

UR - http://www.scopus.com/inward/record.url?scp=63149137763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63149137763&partnerID=8YFLogxK

M3 - Article

C2 - 19080745

AN - SCOPUS:63149137763

VL - 11

SP - 73

EP - 80

JO - Current Oncology Reports

JF - Current Oncology Reports

SN - 1523-3790

IS - 1

ER -